The HEART Pathway is an evidence-based decision tool for identifying emergency department (ED) patients with acute chest pain who are candidates for early discharge, to reduce unhelpful and potentially harmful hospitalizations. Guided by the Consolidated Framework for Implementation Research, we sought to identify important barriers and facilitators to implementation of the HEART Pathway. Study Setting: Data were collected at 4 academic medical centers. Study Design: We conducted semi-structured interviews with 25 key stakeholders (e.g., health system leaders, ED physicians). We conducted interviews before implementation of the HEART Pathway tool to identify potential barriers and facilitators to successful adoption at other regional academic medical centers. We also conducted postimplementation interviews at 1 medical center, to understand factors that contributed to successful adoption. Data Collection: Interviews were recorded and transcribed verbatim. We used a Consolidated Framework for Implementation Research frameworkdriven deductive approach for coding and analysis. Principal Findings: Potential barriers to implementation include time and resource burden, challenges specific to the electronic health record, sustained communication with and engagement of stakeholders, and patient concerns. Facilitators to implementation include strength of evidence for reduced length of stay and unnecessary testing and iatrogenic complications, ease of use, and supportive provider climate for evidence-based decision tools. Conclusions: Successful dissemination of the HEART Pathway will require addressing institution-specific barriers, which includes engaging clinical and financial stakeholders. New SMART-FHIR technologies, compatible with many electronic health record systems, can overcome barriers to health systems with limited information technology resources.
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of the HEART Pathway in 4 academic medical centers in North and South Carolina. There are nearly 50 theoretical frameworks in the implementation science literature, 17 but these are underused. 18 In response to calls for increased use of theory in implementation research, 19 Damschroder et al. 20 integrated the numerous published theories into a single, consolidated framework to guide implementation research. Thus, the Consolidated Framework for Implementation Research (CFIR) is a meta-theoretical framework. We selected the CFIR for this study because it was comprehensive, theory-based, and provided standardized terminology and definitions for constructs across the spectrum of implementation research. The CFIR consists of 5 overarching domains: (1) intervention characteristics (e.g., relative advantage, complexity of the decision tool, costs); (2) outer setting (e.g., competitive advantage, patient needs, and preferences); (3) inner setting (e.g., implementation climate, compatibility with existing workflow, relative priority); (4) individual characteristics (e.g., knowledge and beliefs about the decision tool, stages of change); and (5) process (e.g., planning rollout, engaging institutional leaders). 21 Within these domains are 39 constructs to help determine whether an implementation may or may not be successful (Appendix A).
Although the CFIR framework can be applied before, during, or after implementation, to date, only 3 studies have used it in the preimplementation phase. 20, 22 Thus, we identified factors that contributed to successful implementation at 1 academic medical center (postimplementation), and those that may influence implementation at 3 other academic medical centers (preimplementation). Our findings will be used to (a) refine our implementation strategy (but not adapt the risk stratification tool to local practices), and (b) inform the design and execution of a future multi-site cluster randomized controlled trial.
METHODS

Study Design and Setting
We conducted semi-structured interviews with 25 key stakeholders across 4 academic medical centers in North and South Carolina. These sites are members of the Carolinas Collaborative, a learning health system and data sharing network of Clinical Translational Science Awards sites. The Collaborative was developed to enhance the quality of health care and accelerate advances in research in institutions in North and South Carolina. Each institution's ED sees approximately 100,000 patients per year.
Sample and Recruitment
We used purposive sampling to identify key stakeholders at each site with influence over implementation of the HEART Pathway. The stakeholders' roles and rationale for inclusion are shown in Table 1 . Stakeholders were contacted by e-mail and invited to participate in a 30-minute telephone interview. Of the 30 stakeholders contacted, 2 declined and 3 did not respond (overall response rate 83%). For these 5 individuals, we identified substitutes. Before the interviews, we sent an overview of the HEART pathway algorithm, summary of findings showing advantages over usual care, and copies of relevant publications. We obtained verbal informed consent for all participants.
Ethics Approval and Consent
The Wake Forest University Health Sciences Institutional Review Board approved this study (IRB00038986). The first author obtained verbal informed consent from study participants prior to initiating any study activities.
Data Collection
At the site where the HEART Pathway was implemented, we interviewed participants postimplementation. Respondents from other sites were asked about their readiness, infrastructure, and expected experience implementing the HEART Pathway. Because participants had different roles across institutions, not everyone was asked the same questions, but the core elements of inquiry were consistent throughout the interviews. All interviews were conducted by the first author. Interviews averaged 22 minutes in length (excluding consenting time), were digitally audio-recorded, and transcribed verbatim.
Measures
The interview guide covered all 5 CFIR domains. The study team selected CFIR constructs to inform the interview structure after an in-depth interview with the developer of the HEART Pathway postimplementation, a tour of the ED that had fully integrated the tool into care delivery, and observation of the decision tool in the EHR and on a handheld device. These additional steps were taken to enable the study team to better understand the perspectives of the HEART Pathway's end users.
Data Analysis
The CFIR constructs were also used as qualitative coding guidelines. For consistency, one member of the research team (second author) conducted the thematic content analysis, using a deductive (theory-driven) approach. 23 Interviews were reviewed, and a codebook was developed using the CFIR framework. When applying codes, any questions about applicability were discussed and resolved 
RESULTS
Barriers and facilitators, organized by the 5 CFIR domains, are shown in Table 2 Quotes from some participants are included to support selection of themes. To protect respondent confidentiality, we have grouped all health system leaders and blinded institutional names. Participants are identified after each quote by an identification number constructed from their roles (number) and institutions (letter) as described in Table 1 .
Intervention Characteristics
Evidence Strength and Quality
Respondents felt the existing evidence of the HEART Pathway's effectiveness was compelling, but that a multi-site trial was necessary. A sample response from a health system leader was, 
Complexity
The HEART Pathway was perceived by most respondents as relatively simple conceptually and technically. This sentiment was strongest among the ED physicians-the actual end users:
"… one of the more straightforward workflows that we have." (2A1)
Cost
Respondents' concerns about cost focused on time and resources, specifically (1) the time it takes to reach consensus among many stakeholder groups, and (2) the computer expertise and administrative resources needed to integrate the tool in the EHR, educate end users, monitor implementation and provide feed data back to providers in a timely fashion to support the desired behavior changeall of which were deemed essential to successful implementation. A typical response was,
"I think some of the costs are the time it takes and the resources it takes, including people's time, to get agreement;…the time it takes to educate; the resources it takes to implement it into our EMR (electronic medical record); the resources it takes to review when we review cases ..." (2B1)
Outer Setting
Patient Needs
Respondents discussed how decreases in length of stay and admissions could directly benefit patients, and how decreases in unnecessary testing would reduce the rate of false-positive results and free up resources for other patients. As 1 provider said,
"Using this pathway can reduce the amount of time the patient is in the hospital and the ED, and that is important to patients". (3A)
A health system leader noted, The patient advocate discussed patient needs at length, emphasizing patient safety and including the patient in the decision to discharge. To illustrate, she said:
"A significant portion of our ED visits is related to CP [chest pain] evaluations. If it hastens the throughput there, I think not only does it make us better, potentially, at caring for this specific population, but it enhances our capacity to deal with all of the other folks that need us as well." (1C1)
"…most of all I do not want the patient to be shortchanged with a new system that isn't adequate or not tested or researched enough and a patient loses life or time as a result… At least let us, the patient, feel that all of the decisions you are making are based on me with healthy outcome. Not based on the insurance industry, staff time, or how much it is going to cost." (5E)
The patient advocate also voiced concerns about biases against patients on the basis of gender, race/ethnicity, or culture.
"I just want to have some safeguard that he [biased physician] is not going to utilize this [tool] as a way of not really having to deal with a patient." (5E)
Both providers and the patient advocate noted that the HEART Pathway does not focus on follow-up with patients after discharge, which can be very important as part of clinical care. 
"…ensuring that you order appropriately and the patient knows why you are doing it and how to do it and then somebody following up on those results is going to be key. So, when you say 'early discharge' for all of these things, often times there may be some further follow-up that is necessary for the patient." (2D3)
Peer Pressure
Opinions were mixed about whether the HEART Pathway would afford a competitive advantage over other area medical centers. 
Inner Setting
Networks and Communications
Respondents expressed the need for formal and repeated communication to all stakeholder groups involved in implementation. 
Culture
Respondents described how decisions were typically made regarding care pathways in the ED and how change happens. Many mentioned the benefit of aligning ED initiatives with institutional priorities to garner cross-departmental and institutional support. Where the HEART Pathway was implemented, it was prioritized because:
"It was addressing a clinical need in an area of inefficiency for the hospital and it got a lot of visibility because of the endorsement of the Dean and our CMO." (2A2)
Many respondents discussed the benefit of seeking ED physician input and building consensus across stakeholder groups versus pure 'top-down' decision-making.
"Generally, [decision-making] is building consensus. There are a few really good examples of top-down decisions that have just wildly failed…the top-down things generally don't go well with ED docs...." (2D2)
Implementation Climate
Receptivity to future implementation of the HEART Pathway was perceived as generally high. Respondents noted that receptivity required support and buy-in from many levels of the organization, and evidence of the tool's value (see Evidence Strength). One health system leader stated, Respondents noted that even among ED physicians they expected some variation in receptivity. Several respondents noted there may be support for the tool because their ED physicians were characterized by openness to trying new ways to improve efficiency of care. Others noted that there may be resistance to the tool by ED physicians averse to risk and by older physicians with a longer history and preference for using their own experience as their guide, rather than a protocolized pathway.
Relative Priority
Respondents were asked what level of priority HEART Pathway implementation would be given. Some institutions established governance and workgroups to oversee project prioritization within the EHR, with a sequence of approvals needed before projects are executed. For example, 1 site used a matrix to score project priorities, while workgroups were assigned to keep projects moving forward. Respondents noted that clinical and research projects were handled by different governance structures within their institution, and that priority of EHR programming resources to implement the HEART Pathway would differ depending on which committee reviewed it. One respondent stated:
"If this were not connected with research and were just a general activity that the ED was doing, it would need to get in line with the [many]… projects we have running right now inside the information systems group. The thing is that by having dedicated research resources and by this being dedicated research program you know, if this activity has funding we can move it to the front of the line." (1D2)
However, other respondents felt that high-priority projects were those backed by institutional commitment, which addressed a clinical need, regulatory compliance, or patient safety. Respondents agreed that once a project reached top priority, the time to implementation depended on (a) levels of resources; (personnel), (b) competing priorities; and (c) the extent of coordinated, collaborative support. Once projects were approved, medical centers with multiple sites often implement changes system-wide; this approach to implementing the HEART Pathway would be challenging in terms of resources, standardization, timing, communication, and widespread buy-in.
"I think the issue is resources, because you give people money and that doesn't do any good at all if your certified builders already have other things to do. Resources don't automatically appear just because there is funding… raining money down does not solve the problem, because it's a resource issue." (1C2)
Readiness for Implementation
Although receptive to the HEART Pathway, respondents generally did not express readiness to implement it. When asked how prepared his ED is to adopt the HEART Pathway, one ED physician responded simply, "Probably not very. " (2C2) All 3 subconstructs of the CFIR readiness for implementation construct were identified as relevant: leadership engagement, available resources, and access to knowledge and information.
Leadership Engagement
"Buy-in" was described as a culmination of leadership engagement, institutional commitment, and a willingness to complete implementation at all levels by allocating necessary resources. Based on his experience with implementation of the HEART Pathway, 1 respondent noted that "getting the institutional commitment or political will to allocate time and resources to it in a complex environment" (1A1) was central to their success.
"I think that it's boots-on-the-ground buy-in that you have to get. You have to get people to use it." (2D2) "I think the key is getting people involved -getting stakeholders involved, and the earlier the better." (1A3)
"You want people to buy into it, but you also aren't going to accommodate the whims of each individual practitioner in the application so it's not going to be a total democracy, right? …getting buy-in when it's going to be hundreds of physicians can be challenging…first you have to have all of the leadership agree and find where the areas of tension are likely to be within the providers and figure out ways in application to address those areas of potential tension." (2B2)
Available Resources
Respondents were unsure that their institution's programming support could efficiently implement the HEART Pathway. Although there were conflicting opinions among IT experts about the extent to which the programming could be shared between sites, overall, respondents felt the programming/configuration process would not be complicated, given the proper resources in personnel.
"We are all on EPIC, so if we can leverage what has been done at [site that developed pathway], it would help a lot…" (1B4)
"Oh my gosh, no [the code can't be cut/pasted]. I mean the difference between EPIC at [one site] and EPIC at [another site] and EPIC at [another site] is really pretty amazing." (1C2)
Access to Knowledge and Information
The site that had created and implemented the HEART Pathway noted that workflow was discussed in teams in the preparation and information-sharing phases of implementation.
"..that's where a lot of that time and energy was spent -trying to find a way that was not obstructive to the workflow, yet still met the needs of trying to maintain the validity of the intervention." (2A2)
The other sites also recognized workflow as a viable concern in the implementation process. Respondents noted that successful rollout would require "
taking a look at what the workflow is and how do you embed this to become a natural part of the workflow. " (1D1)
"The biggest reason I think a policy does not create change is when that policy adds work to the provider. So, if I am being encouraged to do something -two things: It adds an additional work burden, task saturation, to me during my busy ED shift and particularly if that additional work burden does not seem to have a positive effect on patient care, I think that combination of increased work plus not having a big payoff is one of the big barriers." (2D1)
Characteristics of Individuals
Knowledge and Beliefs about the Intervention
Respondents were positive about the intervention and felt it could standardize patient management, create shorter decision-making times, decrease adverse outcomes, improve provider satisfaction, and reduce admissions.
"I think the upside of this one in particular is actually you get to a disposition decision quicker. "(1D1)
Among respondents, ED physicians had the most knowledge of the principles of the HEART Pathway and were especially enthusiastic about implementing it.
"I would love it [to be used in my ED]. I think it would really strengthen our ability to standardize CP management or ACS management and risk stratification. I am huge proponent of it… (2D1)
Other Personal Attributes
Despite their own support of the tool, respondents also recognize that others may be resistant or slow to adopt.
"The younger physicians who are more adept at technology may feel more comfortable with pathways. People on the more senior side may have, 'well that's not how I do things', and may be more set in their ways, for lack of a better term." (1D1) "I think the challenge initially is actually not getting buy in from cardiology, but it is the risk aversive nature or not of the ER staff…" (1D3)
Process
Planning
Several respondents voiced concerns about whether support for the HEART Pathway would be sustained during a lengthy implementation process.
"Once we come up to an agreement that this is what we are going to do and everybody is on the same page, then we need to push the development very quickly because people are going to know you are doing this and you don't want to lose momentum. If this kind of trickles along people are going to be distracted by shiny objects and move on to something else." (1C1)
Engaging
Suggestions for engaging internal stakeholders during the planning phase included having internal discussions to determine:
(1) what other health systems do; (2) EPIC system configuration; (3) determining what outcomes to collect and how that data will be extracted and shared with providers to monitor implementation success; (4) impact on workflow; and (5) interface with the EHR. Respondents felt it was important to engage opinion leaders (individuals with formal or informal influence on attitudes and behaviors of their colleagues regarding implementation); formally appointed internal implementation leaders; and champions (individuals who dedicate themselves to supporting, marketing, problem-solving, and advancing an implementation through to full adoption). External change agents such as policy makers or professional associations were not mentioned as relevant. Overall, respondents agreed that education and training for the HEART Pathway rollout are needed, preferably in an ongoing, focused effort to capture all health care providers in the ED, and allowing for staff turnover. 
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"…the education of it has to be multi-pronged…faculty
Reflecting and Evaluating
Respondents expressed a need to monitor adoption and outcomes of the intervention, both for patients and clinicians. Monitoring would include feedback and regular information-sharing with all institutional stakeholder groups. This process would require report generation from IT.
"Was there improvement from an efficiency perspective or something else that may save them time or benefit the patients from a safety perspective that this was a good reason to be able to use this pathway?" (1B2)
DISCUSSION
Despite evidence of the significant quality and value benefits of using the HEART Pathway compared with usual care, to date few hospitals have adopted it. Most hospitals use either no standardized risk stratification tool (relying only on clinician opinion) or use outdated tools not designed for ED use.
Key Facilitators
Our interviews identified several possible facilitators to widespread HEART Pathway dissemination and implementation. At some institutions, there was broad enthusiasm for the tool's ease of use and streamlined workflow. Respondents identified how HEART Pathway implementation could support institutional priorities, including more appropriate inpatient bed capacity, increased efficiency, and standardization. This included faster disposition decisions that reduced ED length of stay. Respondents felt leadership could effectively engage all stakeholders to create change: leaders are best equipped to identify potential barriers and derive solutions that are agreeable to all stakeholders to achieve buy-in throughout the organization.
Key Barriers
Our key informant interviews also identified common barriers to widespread HEART Pathway dissemination and implementation. These included (a) concerns about the time and resources required to implement at their facilities, especially IT resources; (b) prioritization among other projects; and (c) administrative resources needed for full implementation. Respondents stressed the importance of buy-in from key leaders and local champions. Communicating value to the patient (reduced iatrogenic risks and time spent hospitalized and to providers (decreased work load via increased operational efficiency, increased access and decreased low-value testing) was important.
There were also concerns about getting institutional buy-in from the multiple health system stakeholders to overcome existing workflow inertia. While stakeholders may recognize that care processes are inefficient, that does not inevitably result in agreement on a solution. For example, a large health system in Texas considered HEART Pathway implementation; cardiologists were in favor of HEART Pathway adoption but ED physicians were not. Ultimately, this disagreement dissuaded health system leadership from HEART Pathway implementation (personal communication).
Our patient advocate had concerns about whether a standardized pathway would be used to justify biased care or could lead to abandoning patients without appropriate follow-up care. A communication strategy should be in place before implementation, to educate both providers and patients on the value of the HEART Pathway. There is evidence that standardized protocols can lead to more equitable care processes 25 and can prevent both over testing and avoidance of iatrogenic complications from unnecessary testing. The ability to go home earlier was not mentioned as a benefit from the patient perspective; this may reflect a patient bias toward increased testing, even low-value testing. Patients frequently overestimate the risk of mortality from undiagnosed ACS, which could inform different valuation of stress testing and admission in low-risk CP. 26 Alternatively, our patient advocate's remarks may reflect a concern that the HEART Pathway is something being "done to" a patient, not a management plan created with the patient. To this end, some health systems have combined the HEART Pathway, which does not explicitly use shared decision-making, with a validated shared decision-making tool.
27
Potential Solutions to these Barriers
To address technical barriers, our research team has recently developed a SMART-FHIR HEART Pathway application that can be easily downloaded by health systems to their EHR. SMART-FHIR is compatible with many EHR systems, which allows health care clinical decision support applications to be implemented more quickly by hospitals using fewer information technology resources. The HEART Pathway CDS application can be downloaded to a health system's EHR, akin to downloading applications to phones. However, SMART-FHIR is a new technology. EPIC and Cerner have only recently deployed their app stores and made them available to hospital systems nationwide. Currently, the HEART Pathway is among only 17 apps validated on the Epic App Orchard; Fig. 2 ), so health systems have yet to meaningfully embrace the EHR app store model. Likewise, our team has yet to implement the HEART Pathway in a health system using the app store model, but this is a strategy around limited IT resources.
Caveats and Limitations
Our interview sites may not reflect the environment elsewhere. On 1 hand, academic medical centers have greater IT and other resources than smaller centers, but also more stakeholders and/ or clinical sites, requiring more advanced coordination for any implementation process. Significant regional variation in the treatment approach to patients with ACS is evident. 28, 29 Thus, our centers may show variations in their diagnostic approach to CP that makes our experience less generalizable. Smaller centers wishing to adopt the HEART Pathway may need to arrange off-hour cardiac testing so that physicians can reasonably meet a new standard of care that suggests admission or cardiac imaging for higher risk patients. Finally, we did not assess all constructs of the CFIR (although the CFIR developers consider this acceptable). The interview guide was kept succinct to increase the likelihood that busy health system leaders would participate in the study.
Having only 1 institution with experience with HEART Pathway implementation is a potential limitation of this study. However, we used the CFIR framework both retrospectively, albeit only at 1 site, and prospectively, at 3 sites, to inform future implementation efforts. While the prospective recommendations reflect theoretical adoption of a protocol, they come from health care system leaders with extensive experience with both successful and failed efforts to change care delivery in academic medical centers. Furthermore, commonalities among their responses provide face validity for which key stakeholders need to be "on board" for a care pathway to be successfully adopted, who the most effective "champion" for an ED based CP protocol would be, which key administrative leaders' support is necessary for successful adoption, and which key barriers must be overcome for successful implementation of the HEART pathway. This prospective approach engaged relevant stakeholders so that they could exert meaningful influence on the design of future implementation efforts in order to maximize success.
Future Research
Future research should examine a broader range of patients (including those who had and had not been treated according to the HEART pathway), patients' perceptions of personalized versus standardized care and whether they can tell the difference, and what outcomes matter to them when they present to the ED with CP. Postimplementation interviews will be critical to assess the predictive value of the baseline assessments to further advance the field of implementation science.
CONCLUSION
Our assessment, driven by a comprehensive implementation framework, pointed to several strong facilitators to implementing a risk stratification tool for ED patients with acute CP and several barriers. The barriers are all determined locally and should be adequately addressed in future efforts to implement the tool in academic medical centers. Our results suggest that successful dissemination of the HEART Pathway will require a well-developed plan to engage health systems. This will require aligning key stakeholders by providing convincing arguments about the value of using the HEART Pathway. FIGURE 2. This is a screen shot from the HEART Pathway app. The app opens in the electronic record environment (i.e., Epic or Cerner) contextually based on the combination of a complaint of CP and troponin ordered or based on manual selection by the provider. In this screen shot, the provider has selected the patient's symptoms from a drop down list-the provider has indicated that the patient has middle or left-sided CP, which is pinpoint/well localized, sharp, is not associated with heaviness, tightness, or pressure, and is not worse with exertion. The next button allows the provider to access the subsequent section of the app to input additional historical and clinical data and ultimately receive a HEAR score and assessment of the patient's risk for adverse cardiac events. Relative priority Individuals' shared perception of the importance of the implementation within the organization. 4 Organizational incentives and rewards
APPENDIX A. CFIR Constructs
Extrinsic incentives such as goal-sharing awards, performance reviews, promotions, and raises in salary, and less tangible incentives such as increased stature or respect. 5
Goals and feedback The degree to which goals are clearly communicated, acted upon, and fed back to staff, and alignment of that feedback with goals. Access to knowledge and information
Ease of access to digestible information and knowledge about the intervention and how to incorporate it into work tasks. IV. Characteristics of individuals A Knowledge and beliefs about the intervention Individuals' attitudes toward and value placed on the intervention as well as familiarity with facts, truths, and principles related to the intervention. B Self-efficacy Individual belief in their own capabilities to execute courses of action to achieve implementation goals. C Individual stage of change Characterization of the phase an individual is in, as he or she progresses toward skilled, enthusiastic, and sustained use of the intervention. D Individual identification with organization A broad construct related to how individuals perceive the organization, and their relationship and degree of commitment with that organization. E Other personal attributes A broad construct to include other personal traits such as tolerance of ambiguity, intellectual ability, motivation, values, competence, capacity, and learning style. V. Process A Planning The degree to which a scheme or method of behavior and tasks for implementing an intervention are developed in advance, and the quality of those schemes or methods. B Engaging Attracting and involving appropriate individuals in the implementation and use of the intervention through a combined strategy of social marketing, education, role modeling, training, and other similar activities. 
